Artículos por temáticas

Effectiveness of multidisciplinary care for Parkinson's disease: a randomized, controlled trial.

van der Marck MA, Bloem BR, Borm GF, Overeem S, Munneke M, Guttman M.

Mov Disord. 2013 May;28(5):605-11. doi: 10.1002/mds.25194.

Survival and functional restoration of human fetal ventral mesencephalon following transplantation in a rat model of Parkinson's disease.

Rath A, Klein A, Papazoglou A, Pruszak J, Garcia J, Krause M, Maciaczyk J, Dunnett SB, Nikkhah G.

Cell Transplant. 2013;22(7):1281-93. doi: 10.3727/096368912X654984.

Remodeling of the fovea in Parkinson disease.

Spund B, Ding Y, Liu T, Selesnick I, Glazman S, Shrier EM, Bodis-Wollner I.

J Neural Transm (Vienna). 2013 May;120(5):745-53. doi: 10.1007/s00702-012-0909-5.

Neuropsychological and emotional correlates of personality traits in Parkinson's disease.

Koerts J, Tucha L, Leenders KL, Tucha O.

Behav Neurol. 2013 Jan 1;27(4):567-74. doi: 10.3233/BEN-129017.

Lack of non-voluntary stepping responses in Parkinson's disease.

Selionov VA, Solopova IA, Zhvansky DS, Karabanov AV, Chernikova LA, Gurfinkel VS, Ivanenko YP.

Neuroscience. 2013 Apr 3;235:96-108. doi: 10.1016/j.neuroscience.2012.12.064.

Effectiveness of occupational therapy in Parkinson's disease: study protocol for a randomized controlled trial.

Sturkenboom IH, Graff MJ, Borm GF, Adang EM, Nijhuis-van der Sanden MW, Bloem BR, Munneke M.

Trials. 2013 Feb 2;14:34. doi: 10.1186/1745-6215-14-34.

A Patient-Based Needs Assessment for Living Well with Parkinson Disease: Implementation via Nominal Group Technique.

Kleiner-Fisman G, Gryfe P, Naglie G.

Parkinsons Dis. 2013;2013:974964. doi: 10.1155/2013/974964.

Motor matters: tackling heterogeneity of Parkinson's disease in functional MRI studies.

Holiga Š, Mueller K, Möller HE, Sieger T, Schroeter ML, Vymazal J, Růžička E, Jech R.

PLoS One. 2013;8(2):e56133. doi: 10.1371/journal.pone.0056133.

Longitudinal assessment of tau and amyloid beta in cerebrospinal fluid of Parkinson disease.

Zhang J, Mattison HA, Liu C, Ginghina C, Auinger P, McDermott MP, Stewart T, Kang UJ; Parkinson Study Group DATATOP Investigators., Cain KC, Shi M.

Acta Neuropathol. 2013 Nov;126(5):671-82. doi: 10.1007/s00401-013-1121-x.

[Optokinetic nystagmus associated with Parkinson's disease].

Likhachev SA, Alenikova OA.

Vestn Otorinolaringol. 2013;(1):41-5. Russian.

Visual hallucinations in photographs in Parkinson's disease.

Vaou O, Saint-Hilaire M, Friedman J.

BMJ Case Rep. 2013 May 22;2013. pii: bcr2012008372. doi: 10.1136/bcr-2012-008372.

Reply: dopamine agonists and delusional jealousy in Parkinson's disease: a cross-sectional prevalence study.

Poletti M, Bonuccelli U.

Mov Disord. 2013 May;28(5):689-90. doi: 10.1002/mds.25444. No abstract available.

Molecule of the month: miRNA and Parkinson's disease protein PARK2.

Shapshak P.

Bioinformation. 2013 Apr 30;9(8):381-2. doi: 10.6026/97320630009381. No abstract available.

Falls in Parkinson disease: analysis of a large cross-sectional cohort.

Parashos SA, Wielinski CL, Giladi N, Gurevich T; National Parkinson Foundation Quality Improvement Initiative Investigators..

J Parkinsons Dis. 2013;3(4):515-22. doi: 10.3233/JPD-130249.

Functional and effective connectivity in subthalamic local field potential recordings of patients with Parkinson's disease.

Hohlefeld FU, Huchzermeyer C, Huebl J, Schneider GH, Nolte G, Brücke C, Schönecker T, Kühn AA, Curio G, Nikulin VV.

Neuroscience. 2013 Oct 10;250:320-32. doi: 10.1016/j.neuroscience.2013.07.028.